BACKGROUND: Cardiac deaths and events tend to cluster within the early-phase after starting dialysis. Our goal is to clarify the influence of severity of coronary atherosclerosis on early-phase death after starting hemodialysis (HD) therapy. PATIENTS AND METHODS: Eighty-three consecutive patients [mean age 62 years; male/female 64/19; diabetic nephropathy in 50 (54%)] with end-stage renal disease who admitted to our hospital to initiate regular HD treatment, and then received coronary angiography within 3 months after first dialysis therapy, were eligible for this study. Angiographical severity of coronary atherosclerosis was scored by numerically using Gensini scoring system. The patients who died within one year from starting HD were compared with those who survived as control by means of logistic regression analysis. RESULTS: Of 83 patients, 12 (14%) died less than one year after starting dialysis therapy. Of these 12 patients, nine died for cardiac causes. Confirmed predictors of death from cardiac cause were older age (>70 years), lower mean blood pressure (<100 mmHg), presence of ischemic heart disease (IHD), myocardial infarction (MI), angina pectoris (AP), chronic heart failure (CHF), poor cardiac function, abnormal wall motion of left ventricule (LV) and angiographical severity of coronary atherosclerosis by univariate model. Adjusting for confounding variables by multivariate model, only severity of coronary atherosclerosis (Gensini score >40 points) had a powerful influence, increasing risk for cardiac cause of early-phase death by about 17 times. CONCLUSIONS: Severity of coronary atherosclerosis predicts death in the first year of HD. These findings suggest that the strategy for prevention of coronary atherosclerosis should be instituted during the early phase of chronic renal failure.
BACKGROUND:Cardiac deaths and events tend to cluster within the early-phase after starting dialysis. Our goal is to clarify the influence of severity of coronary atherosclerosis on early-phase death after starting hemodialysis (HD) therapy. PATIENTS AND METHODS: Eighty-three consecutive patients [mean age 62 years; male/female 64/19; diabetic nephropathy in 50 (54%)] with end-stage renal disease who admitted to our hospital to initiate regular HD treatment, and then received coronary angiography within 3 months after first dialysis therapy, were eligible for this study. Angiographical severity of coronary atherosclerosis was scored by numerically using Gensini scoring system. The patients who died within one year from starting HD were compared with those who survived as control by means of logistic regression analysis. RESULTS: Of 83 patients, 12 (14%) died less than one year after starting dialysis therapy. Of these 12 patients, nine died for cardiac causes. Confirmed predictors of death from cardiac cause were older age (>70 years), lower mean blood pressure (<100 mmHg), presence of ischemic heart disease (IHD), myocardial infarction (MI), angina pectoris (AP), chronic heart failure (CHF), poor cardiac function, abnormal wall motion of left ventricule (LV) and angiographical severity of coronary atherosclerosis by univariate model. Adjusting for confounding variables by multivariate model, only severity of coronary atherosclerosis (Gensini score >40 points) had a powerful influence, increasing risk for cardiac cause of early-phase death by about 17 times. CONCLUSIONS: Severity of coronary atherosclerosis predicts death in the first year of HD. These findings suggest that the strategy for prevention of coronary atherosclerosis should be instituted during the early phase of chronic renal failure.
Authors: T Shinzato; S Nakai; T Akiba; C Yamazaki; R Sasaki; T Kitaoka; K Kubo; T Shinoda; K Kurokawa; F Marumo; T Sato; K Maeda Journal: Nephrol Dial Transplant Date: 1997-05 Impact factor: 5.992
Authors: Nicola Kumar; Christopher S R Baker; Kakit Chan; Neill Duncan; Iqbal Malik; Andrew Frankel; Damien R Ashby; Adam McLean; Andrew Palmer; Tom D Cairns; David Taube Journal: Clin J Am Soc Nephrol Date: 2011-07-07 Impact factor: 8.237
Authors: Tara I Chang; David Shilane; Dhruv S Kazi; Maria E Montez-Rath; Mark A Hlatky; Wolfgang C Winkelmayer Journal: J Am Soc Nephrol Date: 2012-12 Impact factor: 10.121
Authors: Venkatesh L Murthy; Masanao Naya; Courtney R Foster; Jon Hainer; Mariya Gaber; Sharmila Dorbala; David M Charytan; Ron Blankstein; Marcelo F Di Carli Journal: JACC Cardiovasc Imaging Date: 2012-10
Authors: F Fabbian; G Cacici; V De Biase; T Yabarek; C Gangemi; L Franceschini; A De Giorgi; P Benussi; A Lupo; F Portaluppi Journal: Int Urol Nephrol Date: 2010-09-02 Impact factor: 2.370
Authors: Tara I Chang; Maria E Montez-Rath; Thomas T Tsai; Mark A Hlatky; Wolfgang C Winkelmayer Journal: J Am Coll Cardiol Date: 2016-03-29 Impact factor: 24.094
Authors: Tara I Chang; Maria E Montez-Rath; Jenny I Shen; Matthew D Solomon; Glenn M Chertow; Wolfgang C Winkelmayer Journal: J Am Heart Assoc Date: 2014-10-21 Impact factor: 5.501
Authors: M K de Bie; M S Buiten; J I Rotmans; M Hogenbirk; M J Schalij; T J Rabelink; J W Jukema Journal: BMC Nephrol Date: 2017-03-02 Impact factor: 2.388
Authors: Mihály K de Bie; Maurits S Buiten; André Gaasbeek; Mark J Boogers; Cornelis J Roos; Joanne D Schuijf; M Jacqueline Krol; Ton J Rabelink; Jeroen J Bax; Martin J Schalij; J Wouter Jukema Journal: PLoS One Date: 2013-07-10 Impact factor: 3.240